The primary objective of Core B is to produce research grade rAAV vectors in a timely manner for use in the proposed rodent and dog studies of this U54 translational grant. The Vector Core will supply high-titer rAAV vectors of uniform quality to enhance experimental consistency and relieve the burden of large-scale vector production by the individual research laboratories. Moreover, our goal is to provide the vector as a uniform product minimizing lot-to-lot variation and maintaining consistent vector specific activity. This will be accomplished using an Ad-free transient transfection approach for small-scale mouse studies and a scalable producer cell line approach (that we developed) for high-titer rAAV preparations in support of the proposed GRMD dog studies. Innovations such as: (i) improved AAV helper plasmids for transient transfection production of serotypes 1, 6, and 8, (ii) universal purification method for these serotypes, and (iii) highthroughput cell line selection methods to rapidly identify high-titer producer cell lines (>5 x 104 vg per cell), will all be employed The Corning Cell Cube System will be used for high density mammalian cell culture (1010 cells) to achieve vector yields in excess of 1014 DNA vg. Density gradients and HPLC chromatographic methods will be used to isolate highly pure rAAV that is free of adenovirus and cellular protein contaminants, and vector quantity assessed using real-time quantitative PCR. Lastly, purified vector will be subjected to rigorous quality control assays (ie., sterility, replication competent AAV, replication competent adenovirus, endotoxin, total protein) to assure product consistency and uniformity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54NS055958-04
Application #
8130724
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
2014-08-31
Budget Start
2010-09-01
Budget End
2011-08-31
Support Year
4
Fiscal Year
2010
Total Cost
$259,221
Indirect Cost
Name
Nationwide Children's Hospital
Department
Type
DUNS #
147212963
City
Columbus
State
OH
Country
United States
Zip Code
43205
Xu, Rui; Jia, Ying; Zygmunt, Deborah A et al. (2018) An Isolated Limb Infusion Method Allows for Broad Distribution of rAAVrh74.MCK.GALGT2 to Leg Skeletal Muscles in the Rhesus Macaque. Mol Ther Methods Clin Dev 10:89-104
Chicoine, L G; Montgomery, C L; Bremer, W G et al. (2014) Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery. Mol Ther 22:338-347
Chicoine, Louis G; Rodino-Klapac, Louise R; Shao, Guohong et al. (2014) Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin ?2 surrogates. Mol Ther 22:713-24
Mendell, Jerry R; Rodino-Klapac, Louise; Sahenk, Zarife et al. (2012) Gene therapy for muscular dystrophy: lessons learned and path forward. Neurosci Lett 527:90-9
Malik, Vinod; Rodino-Klapac, Louise R; Mendell, Jerry R (2012) Emerging drugs for Duchenne muscular dystrophy. Expert Opin Emerg Drugs 17:261-77
Rodino-Klapac, Louise R; Montgomery, Chrystal L; Mendell, Jerry R et al. (2011) AAV-mediated gene therapy to the isolated limb in rhesus macaques. Methods Mol Biol 709:287-98
Rodino-Klapac, Louise R; Montgomery, Chrystal L; Bremer, William G et al. (2010) Persistent expression of FLAG-tagged micro dystrophin in nonhuman primates following intramuscular and vascular delivery. Mol Ther 18:109-17
Chandrasekharan, Kumaran; Martin, Paul T (2010) Genetic defects in muscular dystrophy. Methods Enzymol 479:291-322
Mendell, Jerry R; Rodino-Klapac, Louise R; Rosales, Xiomara Q et al. (2010) Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D. Ann Neurol 68:629-38
Martin, Paul T; Xu, Rui; Rodino-Klapac, Louise R et al. (2009) Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice. Am J Physiol Cell Physiol 296:C476-88

Showing the most recent 10 out of 11 publications